Latest filing published 03 Sept 2025 for CLINICA BAVIERA, S.A., €21k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Barbara Baviera Diaz Leante in Clinica Baviera, S.A. Over a trading history stretching from 13 October 2022 to 29 August 2025, the count stands at 6 filings.
In open-market terms, that means 5 purchases worth €18k on one side and 1 sale worth €21k on the other. On balance, insiders were net sellers of €2,315. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: no purchases and 1 sale on the market.
Half of the purchases are above €3,015 and half below. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 3 September 2025, reports an open-market sale of €21k in Clinica Baviera, S.A. The last insider purchase was made public on 5 June 2023, 1,231 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from CNMV. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations